Developing a Novel Image Marker to Predict the Clinical Outcome of Neoadjuvant Chemotherapy (NACT) for Ovarian Cancer Patients
Fuente:
arXiv
Enregistré dans:
| Auteurs principaux: | Zhang, Ke, Abdoli, Neman, Gilley, Patrik, Sadri, Youkabed, Chen, Xuxin, Thai, Theresa C., Dockery, Lauren, Moore, Kathleen, Mannel, Robert S., Qiu, Yuchen |
|---|---|
| Format: | Preprint |
| Publié: |
2023
|
| Sujets: | |
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
Trends and Outcomes of Neoadjuvant Chemotherapy for Clinical Stage T1 Pancreatic Cancer
par: Shruti Koti, et autres
Publié: (2024)
par: Shruti Koti, et autres
Publié: (2024)
Assessing Sarcopenia in Advanced‐Stage Ovarian Cancer Patients Undergoing Neoadjuvant Chemotherapy: A Case Series
par: Christelle Schofield, et autres
Publié: (2024)
par: Christelle Schofield, et autres
Publié: (2024)
Predicting Response to Neoadjuvant Chemotherapy in Ovarian Cancer from CT Baseline Using Multi-Loss Deep Learning
par: Pastori, Francesco, et autres
Publié: (2026)
par: Pastori, Francesco, et autres
Publié: (2026)
Correction to “Utilization and Survival Outcomes of Neoadjuvant Chemotherapy for Early‐Stage Gastric Cancer”
Publié: (2025)
Publié: (2025)
Marshall University Bucks the Trend.
par: Gilley, J. Wade
Publié: (1997)
par: Gilley, J. Wade
Publié: (1997)
Clinical Study of Preoperative Prehabilitation Synchronized Neoadjuvant Chemotherapy for Gastric Cancer Patients
par: Li Li, et autres
Publié: (2024)
par: Li Li, et autres
Publié: (2024)
Prognostic and Predictive Markers for Early Stage Triple‐Negative Breast Cancer Treated With Platinum‐Based Neoadjuvant Chemotherapy
par: Zhenhui Zhao, et autres
Publié: (2024)
par: Zhenhui Zhao, et autres
Publié: (2024)
Neoadjuvant Chemotherapy Is Associated With Reduced Amputation Risk in Synovial Sarcoma of the Lower Extremity
par: Charlotte F. Wahle, et autres
Publié: (2025)
par: Charlotte F. Wahle, et autres
Publié: (2025)
Correction to “Chemotherapy Switch for Non‐Response or Progression on Neoadjuvant Chemotherapy for Pancreatic Adenocarcinoma”
Publié: (2026)
Publié: (2026)
Relative Dose Intensity and Outcomes in Elderly Patients With Resectable Pancreatic Cancer Receiving Neoadjuvant Chemotherapy
par: Tsuyoshi Takeda, et autres
Publié: (2026)
par: Tsuyoshi Takeda, et autres
Publié: (2026)
Homofobia e homofobia interiorizada: produções subjetivas de controle heteronormativo?
par: Márcio Alessandro Neman do Nascimento
Publié: (2010)
par: Márcio Alessandro Neman do Nascimento
Publié: (2010)
Impact of TP53 , KRAS , and APC Mutations on Neoadjuvant Chemotherapy Outcomes in Locally Advanced Rectal Cancer
par: Tomohiro Takeda, et autres
Publié: (2025)
par: Tomohiro Takeda, et autres
Publié: (2025)
Discrepancy Between Radiographic and Pathological Response Assessment in Neoadjuvant Treatment for Pancreatic Cancer: A Comparison Between Neoadjuvant Chemotherapy and Neoadjuvant Chemoradiotherapy
par: Satoru Miyahara, et autres
Publié: (2025)
par: Satoru Miyahara, et autres
Publié: (2025)
Breast Cancer Neoadjuvant Chemotherapy Treatment Response Prediction Using Aligned Longitudinal MRI and Clinical Data
par: Ravi, Rahul, et autres
Publié: (2025)
par: Ravi, Rahul, et autres
Publié: (2025)
Clinical Implications of Nutritional Intake in Patients With Esophageal Squamous Cell Carcinoma Receiving Chemoradiotherapy and Neoadjuvant Chemotherapy
par: Yumiko Tamai, et autres
Publié: (2026)
par: Yumiko Tamai, et autres
Publié: (2026)
Impact of Minimally Invasive Surgery on Early and Late Outcomes of Patients With Gastric Cancer Treated Using Neoadjuvant Chemotherapy
par: Gustavo Ferreira Araruna, et autres
Publié: (2024)
par: Gustavo Ferreira Araruna, et autres
Publié: (2024)
Inflammatory Markers‐Based Surgical Pathological Complete Response Prediction After Neoadjuvant Immunotherapy Combined With Chemotherapy in Head and Neck Squamous Cell Carcinoma
par: Yu‐Dong Ning, et autres
Publié: (2026)
par: Yu‐Dong Ning, et autres
Publié: (2026)
A Dynamic Strategic Plan for the Transition to a Clean Bus Fleet using Multi-Stage Stochastic Programming with a Case Study in Istanbul
par: Karimi, Neman, et autres
Publié: (2024)
par: Karimi, Neman, et autres
Publié: (2024)
Interpretable Machine Learning for Predicting Neoadjuvant Chemotherapy Response in Breast Cancer Using the Baseline Clinical and Pathological Characteristics
par: Shan Fang, et autres
Publié: (2025)
par: Shan Fang, et autres
Publié: (2025)
Cusp forms without complex multiplication as $p$-adic limits
par: Dockery, Dalen
Publié: (2024)
par: Dockery, Dalen
Publié: (2024)
A congruence family modulo powers of 5 for generalized cubic partitions via the localization method
par: Dockery, Dalen
Publié: (2025)
par: Dockery, Dalen
Publié: (2025)
Influence of HER2 Changes on Survival Outcomes After Neoadjuvant Chemotherapy in Peruvian Patients With Triple‐Negative Breast Cancer
par: Zaida Morante, et autres
Publié: (2025)
par: Zaida Morante, et autres
Publié: (2025)
Neoadjuvant Chemotherapy Versus Primary Cytoreductive Surgery for Metastatic Endometrial Cancer
par: Dib Sassine, et autres
Publié: (2026)
par: Dib Sassine, et autres
Publié: (2026)
Neoadjuvant Chemotherapy for Retroperitoneal Sarcoma: A Systematic Review and Meta‐Analysis
par: Bernardo Fontel Pompeu, et autres
Publié: (2025)
par: Bernardo Fontel Pompeu, et autres
Publié: (2025)
Neoadjuvant Chemotherapy for Male Breast Cancer: A Retrospective Cohort Study
par: Zejian Yang, et autres
Publié: (2026)
par: Zejian Yang, et autres
Publié: (2026)
Comparative Efficacy of Neoadjuvant Endocrine Therapy, Neoadjuvant Chemotherapy, and Neoadjuvant Chemo‐Endocrine Therapy in Estrogen Receptor–Positive Breast Cancer Patients: A Meta‐Analysis
par: Yi Yuan, et autres
Publié: (2025)
par: Yi Yuan, et autres
Publié: (2025)
Inflammatory Markers may Determine Postoperative Complications in Cases of Peritoneal Carcinomatosis of Ovarian Origin Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
par: Donmez Mustafa, et autres
Publié: (2026)
par: Donmez Mustafa, et autres
Publié: (2026)
Adjuvant Chemotherapy May be Waived for Breast Cancer Nonresponders to Neoadjuvant Chemotherapy: A Population‐Based Large Cohort Study
par: Lixi Li, et autres
Publié: (2025)
par: Lixi Li, et autres
Publié: (2025)
A globalization of L-BFGS and the Barzilai-Borwein method for nonconvex unconstrained optimization
par: Mannel, Florian
Publié: (2024)
par: Mannel, Florian
Publié: (2024)
Automated Prediction of Breast Cancer Response to Neoadjuvant Chemotherapy from DWI Data
par: Nitzan, Shir, et autres
Publié: (2024)
par: Nitzan, Shir, et autres
Publié: (2024)
Comparison of Neoadjuvant Chemotherapy With FLOT and Modified DCF Regimens in Nonmetastatic Gastric Adenocarcinoma
par: Mehdi Pourghasemian, et autres
Publié: (2025)
par: Mehdi Pourghasemian, et autres
Publié: (2025)
Neoadjuvant Chemotherapy Shortens the cfDNA Telomere Length in Breast Cancer Patients
par: İrem Peker Eyüboğlu, et autres
Publié: (2024)
par: İrem Peker Eyüboğlu, et autres
Publié: (2024)
Neoadjuvant Chemotherapy in Resectable Biliary Tract Cancer: A Systematic Review and Metanalysis
par: Rafael Alvim Pereira, et autres
Publié: (2025)
par: Rafael Alvim Pereira, et autres
Publié: (2025)
Regional Relevancy: A Right and a Responsibility--A Perspective on the Community College.
par: Gilley, J. Wade, et autres
Publié: (1972)
par: Gilley, J. Wade, et autres
Publié: (1972)
Does Neoadjuvant Chemotherapy Followed by Radical Cystectomy Improve the Survival of Muscle‐Invasive Bladder Cancer in Real‐World Clinical Practice?
par: Renato Naito, et autres
Publié: (2025)
par: Renato Naito, et autres
Publié: (2025)
Divergent Survival Outcomes With Adjuvant Chemotherapy in Stage IA Ovarian Clear Cell Carcinoma: Insights From the SEER Database
par: Luping Pan, et autres
Publié: (2025)
par: Luping Pan, et autres
Publié: (2025)
Comment On: “Neoadjuvant Chemotherapy Is Associated With Reduced Amputation Risk in Synovial Sarcoma of the Lower Extremity”
par: Mahdi Maloomi, et autres
Publié: (2025)
par: Mahdi Maloomi, et autres
Publié: (2025)
Research of Ultrasonic Shear Wave Elastography in Evaluating the Efficiency of Neoadjuvant Chemotherapy for Breast Cancer
par: Jingjing Luo, et autres
Publié: (2025)
par: Jingjing Luo, et autres
Publié: (2025)
Predictive Value of Neutrophil Extracellular Traps in Neoadjuvant Chemotherapy for Muscle‐Invasive Bladder Cancer
par: Bingqing Shang, et autres
Publié: (2024)
par: Bingqing Shang, et autres
Publié: (2024)
Impact of Neoadjuvant Chemotherapy on Perioperative Morbidity in Combined Resection of Rectal Cancer and Liver Metastases
par: Joy Z. Done, et autres
Publié: (2025)
par: Joy Z. Done, et autres
Publié: (2025)
Documents similaires
-
Trends and Outcomes of Neoadjuvant Chemotherapy for Clinical Stage T1 Pancreatic Cancer
par: Shruti Koti, et autres
Publié: (2024) -
Assessing Sarcopenia in Advanced‐Stage Ovarian Cancer Patients Undergoing Neoadjuvant Chemotherapy: A Case Series
par: Christelle Schofield, et autres
Publié: (2024) -
Predicting Response to Neoadjuvant Chemotherapy in Ovarian Cancer from CT Baseline Using Multi-Loss Deep Learning
par: Pastori, Francesco, et autres
Publié: (2026) -
Correction to “Utilization and Survival Outcomes of Neoadjuvant Chemotherapy for Early‐Stage Gastric Cancer”
Publié: (2025) -
Marshall University Bucks the Trend.
par: Gilley, J. Wade
Publié: (1997)